Literature DB >> 19941522

What is the relative value of the standard anticonvulsants: Phenytoin and fosphenytoin, phenobarbital, valproate, and levetiracetam?

Eugen Trinka1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941522     DOI: 10.1111/j.1528-1167.2009.02368.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


× No keyword cloud information.
  7 in total

1.  [Status epilepticus].

Authors:  B Feddersen; E Trinka
Journal:  Nervenarzt       Date:  2012-02       Impact factor: 1.214

2.  The SAMUKeppra study in prehospital status epilepticus: lessons for future study.

Authors:  Andrew C Schomer; Jaideep Kapur
Journal:  Ann Transl Med       Date:  2016-12

3.  Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus in Adults: A Prospective Randomized Controlled Trial in China.

Authors:  Yingying Su; Gang Liu; Fei Tian; Guoping Ren; Mengdi Jiang; Brian Chun; Yunzhou Zhang; Yan Zhang; Hong Ye; Daiquan Gao; Weibi Chen
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

4.  The Safety and Effectiveness of Intravenous Lacosamide for Refractory Status Epilepticus in the Critically Ill.

Authors:  C R Newey; N M Le; C Ahrens; P Sahota; S Hantus
Journal:  Neurocrit Care       Date:  2017-04       Impact factor: 3.210

Review 5.  Seizures and epilepsy in herpes simplex virus encephalitis: current concepts and future directions of pathogenesis and management.

Authors:  Johann Sellner; Eugen Trinka
Journal:  J Neurol       Date:  2012-04-18       Impact factor: 4.849

Review 6.  Pharmacotherapy for Status Epilepticus.

Authors:  Eugen Trinka; Julia Höfler; Markus Leitinger; Francesco Brigo
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

Review 7.  Efficacy and safety of intravenous valproate for status epilepticus: a systematic review.

Authors:  Eugen Trinka; Julia Höfler; Alexander Zerbs; Francesco Brigo
Journal:  CNS Drugs       Date:  2014-07       Impact factor: 5.749

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.